Table of Contents Author Guidelines Submit a Manuscript
Volume 6, Pages 1278-1297
Research Article

Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia

1TriStem U.K. Limited, Karachi, Pakistan
2Jinnah Postgraduate Medical Centre, Karachi, Pakistan
3Pakistan Medical Research Council, Islamabad, Pakistan
4Kharadar General Hospital, Karachi, Pakistan
5National Medical Centre, Karachi, Pakistan
6Orthopedic and Medical Institute, Karachi, Pakistan

Received 20 March 2006; Revised 17 May 2006; Accepted 28 September 2006

Academic Editor: Jeffrey S. Bartlett

Copyright © 2006 Ilham Saleh Abuljadayel et al.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • V. K. Khurdayan, “Stem cells: Therapeutic present and future,” Drug News & Perspectives, vol. 20, no. 2, pp. 119–128, 2007. View at Publisher · View at Google Scholar
  • Mohammad Amin Moosavi, and Marveh Rahmati, “Retrodifferentiation: A potential strategy for stem cell therapy of leukemic patients,” Medical Hypotheses, vol. 69, no. 6, pp. 1384–1385, 2007. View at Publisher · View at Google Scholar
  • Roberto Gambari, “Alternative options for DNA-based experimental therapy of β-thalassemia,” Expert Opinion on Biological Therapy, vol. 12, no. 4, pp. 443–462, 2012. View at Publisher · View at Google Scholar
  • Jenny C. Barker, Richard A. Voit, and Matthew H. Porteus, “Nuclease mediated targeted genome modification in mammalian cells,” Topics in Current Genetics, vol. 23, pp. 327–352, 2013. View at Publisher · View at Google Scholar